Antiphospholipid antibodies from a patient with primary antiphospholipid syndrome enhance experimental atherosclerosis

Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):215-8. doi: 10.1038/ncpcardio1436. Epub 2009 Jan 13.

Abstract

Background: A 35-year-old man with primary antiphospholipid syndrome and no risk factors for atherosclerosis presented with postinfarction angina.

Investigations: Coronary angiography, intravascular ultrasonography, injection of apolipoprotein-E-knockout mice with patient's IgG.

Diagnosis: Myocardial infarction caused by a newly occluded proximal left circumflex artery. The left anterior descending artery exhibited a recanalized thrombus throughout the vessel.

Management: The patient was managed by intensive angicoagulation including aspirin, clopidogrel, and enoxaparin for 2 months. After follow-up coronary angiography, he was switched to warfarin with a target International Normalized Ratio of 3.5-4.0.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Animals
  • Antibodies, Antiphospholipid / immunology*
  • Antiphospholipid Syndrome / immunology*
  • Atherosclerosis / diagnostic imaging*
  • Coronary Angiography
  • Humans
  • Male
  • Mice
  • Mice, Knockout

Substances

  • Antibodies, Antiphospholipid